Recruiting studies: Envafolimab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolima
Phase 1 · 3 location(s) · Kangabio AUSTRALIA LTD PTY · NCT07260305 Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06055816 Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Strom
Phase 2 · 1 location(s) · Jian Li · NCT07559864 Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Tr
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT06698965 Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Phase 2 · 1 location(s) · Chongqing University Cancer Hospital · NCT06059261 RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT06663007 Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT06791083 ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC
Phase 2 · 1 location(s) · Beijing Hospital · NCT06321081 Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer
Phase 2 · 1 location(s) · Guangdong Provincial People's Hospital · NCT06734182 Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT04770207 Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Phase 3 · 1 location(s) · Sir Run Run Shaw Hospital · NCT05752136 Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07243626 ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Phase 2 · 1 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT04891198 D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Phase N/A · 1 location(s) · Fujian Provincial Hospital · NCT06643208 Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Trac
Phase 1/Phase 2 · 1 location(s) · West China Hospital · NCT07636798 Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Phase 2 · 19 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT05112991 Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05397769 Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC
Phase 3 · 1 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT06123754 Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Me
Phase 2 · 3 location(s) · Sun Yat-sen University · NCT05959356 Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Loc
Phase 2 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07266493 Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Phase 1/Phase 2 · 23 location(s) · 3D Medicines (Sichuan) Co., Ltd. · NCT05024214 Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With E
Phase 2 · 2 location(s) · Anhui Provincial Hospital · NCT06498622

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.